Rustam Kurmaev & Partners has successfully defended Bio-Rad Laboratories in a dispute with Rosstandart, the Russian Federal Agency for Technical Regulation and Metrology.
Bio-Rad Laboratories is the manufacturer of D-10, a high-tech hemoglobin testing system used in diabetes diagnostics. According to RKP “the company believes that Rosstandart incorrectly classified the D-10 system as a measurement device.”
On October 1, 2019, the Moscow Commercial Court upheld Bio-Rad’s claims. Rosstandart’s order, which effectively banned the D-10 testing system from the market, was declared unlawful, and the court ordered Rosstandart to reverse its earlier order and publish an announcement of the reversal on its official website.
U.S.-based Bio-Rad Laboratories manufactures instruments and reagents for the life sciences research market.
The RKP team included Managing Partner Rustam Kurmaev and Attorney at Law Vasily Malinin.
